Biomarin Pharmaceutical Inc
LSE:0HNC
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Biomarin Pharmaceutical Inc
LSE:0HNC
|
US |
|
M
|
Murray & Roberts Holdings Ltd
SWB:LDYA
|
ZA |
|
A
|
Aurubis AG
XBER:NDA
|
DE |
|
Vaudoise Assurances Holding SA
F:VAHB
|
CH |
|
A
|
Alphabet Inc
SGO:GOOGL
|
US |
|
Anglo American Platinum Ltd
F:RPHA
|
ZA |
|
A
|
Air Products and Chemicals Inc
BMV:APD
|
US |
|
Taskus Inc
F:6VY
|
US |
|
W
|
Workday Inc
SWB:W7D
|
US |
|
Coastal Financial Corp (EVERETT)
F:1VD
|
US |
|
F
|
Federal Realty Investment Trust
LSE:0IL1
|
US |
Shareholder Yield
Current shareholder yield for 
0HNC is
hidden
.
Peers Comparison
Shareholder Yield
Buybacks
Buyback Yield measures how much a company reduces its outstanding shares through repurchases, expressed as a percentage.
This metric directly reflects the company’s efforts to return value to shareholders. By reducing the number of shares, buybacks can increase earnings per share and potentially boost the stock's price.
Peers Comparison
Buybacks
Debt Paydown
Debt Paydown Yield measures the amount of debt a company repays within a specific period, shown as a percentage of its market capitalization.
This metric indicates how the company is using its capital to decrease financial liabilities, which can strengthen its financial health and potentially enhance shareholder value.
Peers Comparison
Debt Paydown
Price Appreciation
0HNC Price
Biomarin Pharmaceutical Inc
| Average Annual Return |
N/A
|
| Standard Deviation of Annual Returns |
N/A
|
| Max Drawdown | -17% |
| Market Capitalization | 10.2B USD |
| Shares Outstanding | 192 110 000 |
| Percentage of Shares Shorted |
N/A
|
